entertainment -WSS

entertainment

author：fashion 2025-09-30 06:09:08 - browse：93

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.

The need-to-know this morning:
• Bayer said it prematurely stopped a Phase 3 study in stroke prevention after independent monitors concluded its experimental blood-thinning medicine, called asundexian, showed inferior efficacy compared to a standard treatment. The asundexian study setback is a significant blow to Bayer’s effort to revamp its drug-development pipeline, analysts said.
• Carmot Therapeutics filed paperwork Friday for an initial public offering of undisclosed size. The Berkeley, Calif.-based company is developing drugs that target GLP-1 and GIP to treat diabetes and obesity, similar to Novo Nordisk’s Ozempic/Wegovy and Eli Lilly’s Mounjaro/Zepbound.
• Bristol Myers Squibb and 2Seventy Bio said the FDA will not complete an on-time review of its application seeking to expand the use of Abecma, their CAR-T therapy for multiple myeloma. Instead, the FDA will convene an advisory panel meeting — date to be determined — to examine survival data from an Abecma clinical trial.
• The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. STAT’s Andrew Joseph has more here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

focus

WSS

A timeline of the missing Titanic tourist submersible

Why Eli Lilly’s earnings didn’t quite live up to the hype

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

AMAs digital advisors table RPM coding reform proposal, again

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

entertainment

entertainment

focus

Guidelines to prevent youth baseball injuries need more muscle

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Bright Health sells Medicare Advantage business to Molina

Why Eli Lilly’s earnings didn’t quite live up to the hype

DIEP, the 'gold standard' of breast reconstruction, is under threat

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

New air purifier tech could be key to improving indoor air quality

Tome Biosciences co

Guidelines to prevent youth baseball injuries need more muscle

Report cites 'urgent' need to recruit more diverse clinical trial participants

focus

Resistance to opioid

Artificial intelligence use in health care faces greater scrutiny in 2024

Congress must protect the remaining independent doctors

Greece's new parliament sworn in following conservative party's election victory

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

entertainment

explore

focus

entertainment